
Sign up to save your podcasts
Or


What if you could access GMP manufacturing without giving up control, ownership, or flexibility? In this episode, a new model challenges how biotech companies think about scaling.
This week on Making It In Manufacturing, Harry Sloan sat down with Sarah Stevens, CEO of Chrysalis, with over 20 years of experience spanning CDMO services, technical operations, and leadership roles across biopharma manufacturing.
In this episode, Sarah Stevens covers:
(00:00) How Chrysalis is redefining the CDMO model with a hybrid approach that allows companies to retain control of IP, timelines, and manufacturing processes
(02:20) Why today’s biotech environment demands more flexible, cost-conscious manufacturing strategies and how companies can better manage capital allocation
(04:25) Where biotech companies get manufacturing strategy wrong when balancing speed versus long-term scalability in GMP processes
(08:57) A 20-year career journey from academic research into executive leadership and what drives success in CDMO environments
(13:21) How Chrysalis evolved its model into a scalable and mobile platform, enabling customers to transition seamlessly into their own facilities
If you are navigating manufacturing strategy, scaling operations, or evaluating CDMO partnerships, this episode offers a clear perspective on how to approach flexibility, control, and long-term success in biopharma.
Follow ARTO
LinkedIn: https://www.linkedin.com/company/artotalent
Spotify: https://open.spotify.com/show/0kEcRZOiJChOoN1KF2n1ng
Instagram: https://www.instagram.com/arto.talent?igsh=MWdhbWl5N204a253NQ%3D%3D&utm_source=qr
TikTok: https://www.tiktok.com/@artotalent?_t=ZG-8tHbGACAZaj&_r=1
Apple Podcasts: https://podcasts.apple.com/us/podcast/leading-beyond-the-lab/id1783115575
Website: https://arto-talent.com/
Youtube: https://www.youtube.com/@life_sciences
Sarah Stevens
LinkedIn: https://www.linkedin.com/in/sarah-stevens-1135964
Harry Sloan
LinkedIn: https://www.linkedin.com/in/harry-sloan-605620154/
#MakingItInManufacturing #ARTOTalent #Biopharma #CDMO #GMP #BiotechManufacturing #LifeSciences
Hosted on Acast. See acast.com/privacy for more information.
By ARTO TalentWhat if you could access GMP manufacturing without giving up control, ownership, or flexibility? In this episode, a new model challenges how biotech companies think about scaling.
This week on Making It In Manufacturing, Harry Sloan sat down with Sarah Stevens, CEO of Chrysalis, with over 20 years of experience spanning CDMO services, technical operations, and leadership roles across biopharma manufacturing.
In this episode, Sarah Stevens covers:
(00:00) How Chrysalis is redefining the CDMO model with a hybrid approach that allows companies to retain control of IP, timelines, and manufacturing processes
(02:20) Why today’s biotech environment demands more flexible, cost-conscious manufacturing strategies and how companies can better manage capital allocation
(04:25) Where biotech companies get manufacturing strategy wrong when balancing speed versus long-term scalability in GMP processes
(08:57) A 20-year career journey from academic research into executive leadership and what drives success in CDMO environments
(13:21) How Chrysalis evolved its model into a scalable and mobile platform, enabling customers to transition seamlessly into their own facilities
If you are navigating manufacturing strategy, scaling operations, or evaluating CDMO partnerships, this episode offers a clear perspective on how to approach flexibility, control, and long-term success in biopharma.
Follow ARTO
LinkedIn: https://www.linkedin.com/company/artotalent
Spotify: https://open.spotify.com/show/0kEcRZOiJChOoN1KF2n1ng
Instagram: https://www.instagram.com/arto.talent?igsh=MWdhbWl5N204a253NQ%3D%3D&utm_source=qr
TikTok: https://www.tiktok.com/@artotalent?_t=ZG-8tHbGACAZaj&_r=1
Apple Podcasts: https://podcasts.apple.com/us/podcast/leading-beyond-the-lab/id1783115575
Website: https://arto-talent.com/
Youtube: https://www.youtube.com/@life_sciences
Sarah Stevens
LinkedIn: https://www.linkedin.com/in/sarah-stevens-1135964
Harry Sloan
LinkedIn: https://www.linkedin.com/in/harry-sloan-605620154/
#MakingItInManufacturing #ARTOTalent #Biopharma #CDMO #GMP #BiotechManufacturing #LifeSciences
Hosted on Acast. See acast.com/privacy for more information.